Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-21

FDA Approved: BIVALIRUDIN — Supplemental Application (Dr. Reddy's Laboratories Limited)

View source ↗

Summary

The FDA approved a supplemental application for bivalirudin from Dr. Reddy's Laboratories Limited, indicating an approved change to an existing ANDA for this an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bivalirudin (bivalirudin)

Snippet

SUPPL AP for BIVALIRUDIN (BIVALIRUDIN)